Key Highlights

  • OptiSol partnered with a leading digital health provider to build a Bio-AI model that automates histology image analysis, accelerating drug discovery and treatment research.
  • The solution leverages computer vision and deep learning to identify structural and spectral features in histology images, enabling accurate prediction of pharmacological activity.
  • By automating image segregation based on anomalies and tissue structures, the model eliminates tedious manual processing, handling massive datasets efficiently.
  • The scalable and cost-effective approach benefits pharmaceutical companies, patients, and society by speeding up biomarker development and improving research outcomes.

Problem Statement

01

Data Overload: Manual analysis of thousands of histology images was time-consuming and prone to human error, slowing down drug discovery processes.

02

Complex Features: Histology images contain intricate structural and spectral details, such as nuclei shape and stain intensity, requiring specialized analysis expertise.

03

Resource Constraints: Limited human and computational resources made it challenging to process large datasets accurately and efficiently.

04

Delayed Insights: Manual image processing created bottlenecks in pharmacological research, affecting timely identification of potential drug candidates.

Solution Overview

01

OptiSol developed a Bio-AI deep learning model using Python, TensorFlow, and Keras to automate structural and spectral feature extraction from histology images.

02

The solution integrates multiple data types on an open platform, increasing analysis efficiency and improving success rates in biomarker development.

03

Structural features like shape index, compactness, elliptic fit, and nucleus distance are automatically identified to support precise tissue analysis.

04

Spectral features, including optical density, stain vectors, and intensity for Hematoxylin, Eosin, and residual stains, are accurately calculated for each image.

05

Automated segregation of images based on anomalies enables rapid prioritization and analysis, reducing manual workload while maintaining high accuracy.

Business Impact

01

Accelerated Research: Automation allows faster analysis of large histology datasets, speeding up drug discovery and treatment exploration.
0
%
Reduction in Image Analysis Time

02

Reduced Manual Work: Manual effort in analyzing complex images is minimized, freeing researchers to focus on high-value scientific tasks.
0
%
Decrease in Manual Image Processing

03

Improved Accuracy: Deep learning ensures consistent and precise feature detection, enhancing the reliability of pharmacological predictions.
0
%
Improvement in Prediction Accuracy

About The Project

This success story highlights how OptiSol empowered a leading digital health provider to leverage Bio-AI for histology image processing. By automating the extraction of structural and spectral features from complex tissue images, the solution accelerated pharmacological research, improved accuracy, and reduced manual workload. The scalable and cost-effective approach supports faster drug discovery and treatment analysis, ultimately benefiting pharmaceutical companies, patients, and society at large.

Technology Stack

FAQs:

What is Bio-AI used for?

Bio-AI is an artificial intelligence model that automates the analysis of histology images to support drug discovery and pharmacological research

How does Bio-AI process histology images?

It identifies structural and spectral features like nuclei shape, compactness, optical density, and stain intensity using deep learning and computer vision techniques.

Can Bio-AI handle large datasets?

Yes, Bio-AI is designed to process thousands of histology images efficiently, eliminating manual analysis bottlenecks.

What are structural features in histology images?

Structural features include shape index, compactness, elliptic fit, and nucleus distance, which help characterize tissue morphology.

How does Bio-AI benefit pharmaceutical companies?

By accelerating drug discovery and biomarker development, Bio-AI reduces research timelines and improves decision-making accuracy.

Testimonials of Our Happy Clients

Connect With Us!